Infectious Diseases Biomarker Analysis Lab

Achieve consistent, high-quality biomarker data and streamline your infectious disease clinical trials with MLM Medical Labs. Our clinical biomarker screening services deliver expert support and integrated solutions for reliable endpoint analysis across global study sites.

Specialized Infectious Disease Biomarker Screening Services for Clinical Trials

Developing treatments for infectious diseases demands more than scientific expertise. It requires robust clinical strategies backed by comprehensive biomarker screening services. MLM Medical Labs provides the specialized laboratory support needed to navigate the complexities and accelerated timelines of infectious disease clinical trials.

Our biomarker screening services go beyond traditional methods, supporting both regulatory and exploratory endpoints with analytically validated data across all trial phases and geographies.

Our clinical biomarker screening and infectious disease laboratory capabilities include:

Collaborative protocol design and custom assay development: Validation for the most relevant biomarkers for your study, whether you need standardized panels or assay development for novel biomarkers.
Integrated virology and molecular testing: Comprehensive PCR-based assays, genotyping and pathogen detection to support both routine and high-complexity study needs.
Microbiology and antimicrobial testing: Culture, identification and susceptibility testing for a full spectrum of infectious agents using flexible, study-specific workflows.
Multiplex host-response and cellular biomarker analysis: Broad proteomic, cytokine and flow cytometry profiling for immune monitoring, including immunophenotyping to assess inflammation, sepsis risk or immunological status — studying HIV and other chronic viral infections.
Matrix flexibility: Validated extraction and quantification of biomarkers from plasma, serum, cerebrospinal fluid (CSF) and peripheral blood mononuclear cells (PBMCs).

Streamlining Sample Management and Data Integrity in Global Trials

Infectious disease clinical trials often suffer from data inconsistencies and analyte degradation caused by variable sample collection methods, transit delays or fragmented data systems. MLM Medical Labs mitigates these challenges with integrated, end-to-end solutions.

Standardized Kit Building and Collection

We design custom, study-specific sample collection kits through our MLM Kit Building^® platform, ensuring standardized pre-analytical handling at all global clinical sites.

Integrated Cold-Chain Logistics

Temperature-controlled transport from the investigator site to the central lab protects sensitive analytes, such as RNA and cytokines.

Centralized Data Management and Real-Time Access

All biomarker testing is performed under a harmonized Quality Management System, with secure, 24/7 online access to your global trial data via the mlm online^® portal.

Why Partner With Us for Infectious Disease Biomarkers Testing?

When selecting a partner for clinical biomarker screening, quality, consistency and scientific expertise are paramount. MLM Medical Labs delivers all of these, ensuring your data is reliable and regulatory-ready, wherever your trials take you.

When you choose our teams for biomarker analysis, you benefit from:

Global reach: All laboratory testing is governed by a single, harmonized Quality Management System spanning our U.S., European and South African labs.
Industry-leading accreditations: We have certifications from Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP). Our lab adheres to ISO 15189 and Good Clinical Laboratory Practice (GCLP) standards.
Seamless integration: Our experienced, PhD-led teams provide expert consultation and customized solutions that recognize the unique requirements of each clinical trial.
Rapid startups: Our integrated global network delivers standardized processes and regulatory-grade results while reducing delays and optimizing development timelines across all sites.

Let MLM Medical Labs Support Your Infectious Disease Program

Experience analytically validated biomarker data that stands up to regulatory review and helps accelerate your next trial — whether for antivirals, antibiotics or vaccines. Consult with our scientific experts to map out an assay strategy tailored to your protocol and unlock reliable global sample analysis.

Contact MLM Medical Labs to discuss custom validation solutions for your infectious disease clinical development program.